Pfizer sues Breckenridge over rheumatoid arthritis drug

24-03-2017

Pfizer has sued Breckenridge Pharmaceutical, Pensa Pharma and Laboratorios del Dr Esteve for patent infringement of its drug Xeljanz (tofacitinib). 


Pfizer, Breckenridge, ANDA, FDA, patent, Xeljanz, rheumatoid arthritis, Abbreviated New Drug Application

LSIPR